New injection aims to slow vision loss in rare eye disease
Disease control
Recruiting now
This early-stage trial tests the safety of an experimental drug called ZM-02, given as an injection into one eye of 12 people with retinitis pigmentosa, a condition that causes gradual vision loss. The main goal is to check for side effects and monitor eye pressure. The study doe…
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 02, 2026 05:47 UTC